Ticker
EVOKCompany Name
EVOKE PHARMA INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -3.62M | -28.3% | $ 12.79M |
3/31/2025 | $ -3.88M | -33.44% | $ 11.59M |
12/31/2024 | $ -5.46M | -53.26% | $ 10.25M |
9/30/2024 | $ -5.32M | -61.79% | $ 8.62M |
6/30/2024 | $ -5.55M | -73.72% | $ 7.53M |
3/31/2024 | $ -5.93M | -97.18% | $ 6.11M |
12/31/2023 | $ -4.98M | -96.22% | $ 5.18M |
9/30/2023 | $ -6.39M | -148.46% | $ 4.3M |
6/30/2023 | $ -6.44M | -180.51% | $ 3.57M |
3/31/2023 | $ -6.61M | -227.94% | $ 2.9M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for EVOKE PHARMA INC is calculated as follows: FCF [ $ -6.07M ] / Revenues [ $ 0 ]
(=) FCF % [ 0% ]
Minimum
Dec 31, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.85% |
median | 7.37% |
std | 19.48% |